Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 19;25(16):e202400369.
doi: 10.1002/cbic.202400369. Epub 2024 Aug 2.

Characterization of HphA: The First Enzyme in the Homologation Pathway of l-Phenylalanine and l-Tyrosine

Affiliations

Characterization of HphA: The First Enzyme in the Homologation Pathway of l-Phenylalanine and l-Tyrosine

Laura E Stewart et al. Chembiochem. .

Abstract

Homologation of amino acids is the insertion or deletion of a methylene group to their side chain, which is a relatively uncommon chemical transformation observed in peptide natural product (NP) structure. Homologated amino acids can potentially make the NP more stable in a biological system, but its biosynthesis is yet to be understood. This study biochemically characterized the first of three unexplored enzymes in the homologation pathway of l-phenylalanine and l-tyrosine. Previously proposed reactions catalyzed by HphA were confirmed by reversed-phase high-performance liquid chromatography and tandem mass spectrometry analysis. The substrate profile and kinetic parameters showed high selectivity for the natural substrates and their close analogs. The comparability of HphA to homologous enzymes in primary metabolic pathways, 2-isopropylmate synthase and homocitrate synthase which are involved in l-leucine and l-lysine biosynthesis, respectively, was validated by bioinformatical and site-directed mutagenesis studies. The knowledge obtained from this study has deepened the understanding of the homologation of amino acids, which can lead to future combinatorial biosynthesis and metabolic engineering studies.

Keywords: Anabaenopeptins; Biosynthesis; Enzymology; Homologation; Natural products.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proposed individual enzymatic reactions and intermediates in the homologation of l-Phe (R = H) and l-Tyr (R = OH). The red-colored enzymes are encoded in the biosynthetic gene cluster of anabaenopeptins produced by N. punctiforme PCC 73102.[4] The enzyme utilized in this study HphA is bolded. The second steps of HphA (hydrolysis) and HphB (decarboxylation) are non-enzymatic spontaneous reactions. Each abbreviation depicts the following: ArAT = aromatic amino acid aminotransferase, PPA = phenylpyruvic acid, 4HPPA = 4-hydroxyphenylpyruvic acid, B2HB = 2-benzyl-2-hydroxybutanedioic acid, 4HB2HB = 2-(4-hydroxybenzyl)-2-hydroxybutanedioic acid, B3HB = 2-benzyl-3-hydroxybutanedioic acid, 4HB3HB = 2-(4-hydroxybenzyl)-3-hydroxybutanedioic acid, OPB = 2-oxo-4-phenylbutanoic acid, 4HPOB = 4-(4-hydroxyphenyl)-2-oxobutanoic acid, PLP = pyridoxal 5’-phosphate, CoA = coenzyme A, NAD(P)+ = nicotinamide adenine dinucleotide (phosphate).
Figure 2.
Figure 2.
RP-HPLC analysis to observe the consumption of the substrate PPA by HphA. The solution A (the synthetic standard) contains PPA, B (reaction solution) contains HphA C-His, PPA, and AcCoA, C (reaction without HphA) contains PPA and AcCoA, and D (reaction without AcCoA) contains HphA and PPA.
Figure 3.
Figure 3.
MS/MS analysis for the product of the reaction catalyzed by HphA C-His. A. The commercially available 4HB2HB. B. Extracted sample from the HphA reaction solution. C. Possible fragmentation patterns on 4HB2HB. Because of two hydroxy groups and two carboxyl groups in 4HB2HB structure, fragmentation of one of the two functional groups are indistinguishable. A number of hydrogens cleavable from the hydroxy and carboxyl group might make the observed mass −1 or −2 from the calculated mass. The molecular formulas with labels “a”-“e” correspond to the peaks on the chromatograms.
Figure 4.
Figure 4.
Substrate profile of HphA. The natural substrates are colored red. Each abbreviation depicts the following: PPA = phenylpyruvic acid, 4HPPA = 4-hydroxyphenylpyruvic acid, 3HPPA = 3-hydroxyphenylpyruvic acid, 4MeOPPA = 4-methoxyphenylpyruvic acid, hPPA = homologated pyruvic acid (2-oxo-4-phenylbutanoic acid), InPA = Indole-3-pyruvic acid, ImPA = 4-imidazolepyruvic acid, MOBA = 3-methyl-2-oxobutanoic acid, PA = pyruvic acid, HPA = hydroxypyruvic acid, OAA = oxalacetic acid, αKG = α-ketoglutaric acid. The error bars are the range of the data (n = 2).
Figure 5.
Figure 5.
A. The active site of the enzyme in the structure of homocitrate synthase-α-KG-CoA complex (PDB ID: 6KTQ).[16] The residues in parentheses are those in HphA. The ligands and interacting residues are shown as sticks, and their polar interactions are represented by dotted lines. The catalytic Zn2+ and a coordinated water molecule are shown by magenta and cyan balls, respectively. B. Amino acid sequence alignment with HphA, Neisseria meningitidis LeuA (PDB ID: 3RMJ),[18] Cytophaga hutchinsonii LeuA (PDB ID: 3EEG),[19] and Listeria monocytogenes LeuA (PDB ID: 3EWB).[20] The purple triangles depict conserved amino acid residues in the Zn2+ binding site, and the green triangles depict non-conserved amino acid residues that interact with the side chain of the substrate shown in Figure 5A.
Figure 6.
Figure 6.
Comparison of the activity between HphA wild type (WT) and mutants. The error bar for WT is the standard deviation (n = 4), and the error bars for mutants are the range of the data (n = 2).

Similar articles

  • Prescription of Controlled Substances: Benefits and Risks.
    Preuss CV, Kalava A, King KC. Preuss CV, et al. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
  • Natural Products That Contain Higher Homologated Amino Acids.
    Owens SL, Ahmed SR, Lang Harman RM, Stewart LE, Mori S. Owens SL, et al. Chembiochem. 2024 May 2;25(9):e202300822. doi: 10.1002/cbic.202300822. Epub 2024 Apr 9. Chembiochem. 2024. PMID: 38487927 Free PMC article. Review.
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D. Connock M, et al. Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930

References

    1. Newman DJ, Cragg GM, J. Nat. Prod 2020, 83, 770–803. - PubMed
    1. Owens SL, Ahmed SR, Lang Harman RM, Stewart LE, Mori S, ChemBioChem 2024, e202300822. - PMC - PubMed
    1. Ding Y, Ting JP, Liu J, Al-Azzam S, Pandya P, Afshar S, Amino Acids 2020, 52, 1207–1226. - PMC - PubMed
    1. Koketsu K, Mitsuhashi S, Tabata K, Appl. Environ. Microbiol 2013, 79, 2201–2208. - PMC - PubMed
    1. Amorim Franco TM, Blanchard JS, Biochemistry 2017, 56, 5849–5865; - PMC - PubMed
    2. Kohlhaw GB, Microbiol. Mol. Biol. Rev 2003, 67, 1–15, table of contents; - PMC - PubMed
    3. Binder S, Knill T, Schuster J, Physiol. Plant 2006, 129, 68–78.

LinkOut - more resources